Roche Holding AG Participation (RHHVF OTCQX) stock market data APIs
$330.377
-3.91(-1.2%)
as of July 1, 2025
Try our APIs with
free plan!
Roche Holding AG Participation Financial Data Overview
Price chart is built with
Anychart
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland.
Prev. Close
330.377
Open
326.4698
High
330.377
Low
322.9883
52 wk Range
267.55-354.19
Market Cap
257 805 M
P/E Ratio
25.019
Shares Outstanding
689 M
Revenue
62 395 M
EPS
0
Beta
0.172
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Roche Holding AG Participation data using free add-ons & libraries
Get Roche Holding AG Participation Fundamental Data
Roche Holding AG Participation Fundamental data includes:
- Net Revenue: 62 395 M
- EBITDA: 22 717 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-04-24
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Roche Holding AG Participation News
New
Changes to the Roche Enlarged Corporate Executive Committee
F. Hoffmann-La Roche Ltd Basel, 30 June 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Johannes (Hans) Clevers (1957), M.D., Ph.D., Head of Roche Pharma Research and Early Development...
Initiation of commercialization of ProNephro AKI (NGAL) for diagnostic use in the US
BioPorto A/S June 27, 2025 Announcement no. 18 Initiation of commercialization of ProNephro AKITM (NGAL) for diagnostic use in the US COPENHAGEN, DENMARK and BOSTON, MA, USA, June 27, 2025 – Bio...
Will MRK's Growing Pipeline Help Navigate the Looming Keytruda LOE?
Merck MRK has built a substantial portfolio of new products and pipeline candidates in areas like oncology, vaccines, neuroscience, and infectious disease. Merck’s phase III pipeline has almost tri...
96% of health care executives are "ready and resourced" to use digital health solutions, yet two-thirds say interoperability is "a tough but manageable challenge," reveals new MIT Technology Review Insights report
CAMBRIDGE, Mass., June 25, 2025 /CNW/ -- A new survey report by MIT Technology Review Insights reveals the best practices for success when implementing integrated digital solutions into health care, e...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
